+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

From
From
Alagille syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Alagille syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Chronic Kidney Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Kidney Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Biliary Atresia (BA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Biliary Atresia (BA) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Homocystinuria - Epidemiology Insight - 2032 - Product Thumbnail Image

Homocystinuria - Epidemiology Insight - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Alcoholic Hepatitis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Alcoholic Hepatitis Treatment Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 170 Pages
  • Global
From
Hepatitis B Vaccine Market Report and Forecast 2024-2032 - Product Thumbnail Image

Hepatitis B Vaccine Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 160 Pages
  • Global
From
Lupus Nephritis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Lupus Nephritis Treatment Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
Acute Kidney Injury Treatment Market Report and Forecast 2023-2028 - Product Thumbnail Image

Acute Kidney Injury Treatment Market Report and Forecast 2023-2028

  • Report
  • September 2023
  • 143 Pages
  • Global
From
Erythropoietin Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Erythropoietin Drugs Market Report and Forecast 2023-2031

  • Report
  • June 2023
  • 140 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more